banner_biopharma_4.jpg

Automated crystal growth

For the drug discovery process, X-ray methods help to identify new leads and to validate new targets.

Automated crystal growth generates an appropriate number of targets that are then suitable for single crystal determination with a D8 QUEST or D8 VENTURE system.

Crystalline phase identification, high-throughput polymorph screening (HTS) and determination of the active pharmaceutical ingredients (API) can be performed with our powder diffraction systems: the D8 DISCOVER with GADDS in high-throughput mode, the D8 FOCUS and the D8 ADVANCE.